ArticleCells2025

Comparing a Novel Anti-BCMA NanoCAR with a Conventional ScFv-Based CAR for the Treatment of Multiple Myeloma.

Mégane Jassin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.